A Phase 2 Exploratory Trial Evaluating Computed Tomography–Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal Cancer
Joseph K. Kim(NYU Langone Health), Kenneth S. Hu(Mount Sinai Beth Israel), C.K. Hill(New York University), Elçin Zan(Cornell University), Eddy Solomon(Cornell University), Tsivia Hochman(NYU Langone Health), Catherine Concert(New York University), Michael J. Persky(New York University), Umamaheswar Duvvuri(City University of New York), Jerome M. Karp(Albert Einstein College of Medicine), Cheongeun Oh(NYU Langone Health), Sungheon Kim(Cornell University), Zujun Li(New York University), Moses Tam(NYU Langone Health), Marissa Rybstein(Long Island University), A. Jacobson(Action for ME), Mark S. Persky, Louis B. Harrison(St. Luke's-Roosevelt Hospital Center), Judith D. Goldberg(New York University)
International Journal of Radiation Oncology*Biology*Physics
October 15, 2025
Cited by 2
Related Papers
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
|Cancer Discovery|2013|590
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
|Journal of Clinical Oncology|2006|504